Results 11 to 20 of about 224,084 (383)

Knowledge, attitudes, and practices of the United Arab Emirates population towards Herpes Zoster vaccination: A cross-sectional study

Human Vaccines & Immunotherapeutics, 2022
Herpes Zoster is a viral infection that occurs due to reactivation of the Varicella Zoster virus. A vaccine has been approved for adults aged 50 and above for the prevention of Herpes Zoster and its complications.
Teba Al-Khalidi, Radwa Genidy, Muna Almutawa, Mohammad Mustafa, Saryia Adra, Najem Edeen Kanawati, Thureya Binashour, Hiba Jawdat Barqawi   +7 more
doaj   +2 more sources

Risk of herpes zoster associated with JAK inhibitors in immune-mediated inflammatory diseases: a systematic review and network meta-analysis

Frontiers in Pharmacology, 2023
Objective: Janus kinase (JAK) inhibitors are a novel class of drugs that have shown efficacy in treating immune-mediated inflammatory diseases (IMIDs). However, their safety profile in terms of herpes zoster infection remains unclear.
Qingling Xu, Liyuan He, Yufeng Yin
doaj   +2 more sources

Herpes Zoster Vaccines [PDF]

The Journal of Infectious Diseases, 2021
Abstract Herpes zoster (HZ) affects approximately 1 in 3 persons in their lifetime, and the risk of HZ increases with increasing age. The most common, debilitating complication of HZ is the chronic neuropathic pain of postherpetic neuralgia (PHN).
Michael N. Oxman, Michael N. Oxman, Ruth Harbecke, Ruth Harbecke, Jeffrey I. Cohen   +4 more
openaire   +4 more sources

Herpes zoster in an immunocompetent adolescent – A case of rare occurrence [PDF]

Journal of Family Medicine and Primary Care
Herpes zoster is an acute viral infection caused by the reactivation of the varicella zoster virus. It occurs commonly in immunocompromised adults. Odontalgia may be an early prodromal symptom when herpes zoster involves the oral and maxillofacial region,
A.Winnifred Christy, T. J. R. Devathambi, R. Thanigainathan, M. Gobika Harini   +3 more
doaj   +2 more sources

Chloroquine diphosphate: a risk factor for herpes zoster in patients with dermatomyositis/polymyositis [PDF]

Clinics, 2013
OBJECTIVES: Herpes zoster has been widely described in the context of different systemic autoimmune diseases but not dermatomyositis/polymyositis. Therefore, we analyzed the prevalence, risk factors and herpes zoster outcomes in this population. METHOD:
da Cunha, Gilmara Franco, de Souza, Fernando Henrique Carlos, Levy-Neto, Maurício, Shinjo, Samuel Katsuyuki   +3 more
core   +5 more sources

Global and regional estimates of vaccine-associated herpes zoster and their related vaccines from 1969 to 2023 [PDF]

Scientific Reports
Vaccine-induced immunosuppression can reactivate the varicella-zoster virus, potentially leading to the development of herpes zoster. However, the literature on this topic is inconsistent, resulting in limited clarity.
Jinyoung Jeong, Hyesu Jo, Yejun Son, Jaeyu Park, Jiyeon Oh, Sooji Lee, Yi Deun Jeong, Kyeongmin Lee, Hyeon Jin Kim, Hayeon Lee, Soeun Kim, Yesol Yim, Masoud Rahmati, Jiseung Kang, Raphael Udeh, Damiano Pizzol, Lee Smith, Jiyoung Hwang, Dong Keon Yon   +18 more
doaj   +2 more sources

Cost burden and temporal trends of herpes zoster in China: Evidence from Beijing's health records [PDF]

Preventive Medicine Reports
Objective: Herpes zoster poses a significant health threat to the aging population in China. This study aimed to analyze the cost burden and temporal trends of herpes zoster in China.
Zhenyu Shi, Feng Lu, Yiqi Xia, Ping He
doaj   +2 more sources

Pioneer factors in viral infection

Frontiers in Immunology, 2023
Pioneer factors are transcription factors sharing the fascinating ability to bind to compact chromatin and thereby alter its transcriptional fate. Most pioneer factors are known for their importance during embryonic development, for instance, in inducing
Eva Neugebauer, Eva Neugebauer, Eva Neugebauer, Eva Neugebauer, Aura M. Bastidas-Quintero, Aura M. Bastidas-Quintero, Daniel Weidl, Florian Full, Florian Full, Florian Full   +9 more
doaj   +1 more source

Herpes zoster: A Review of Clinical Manifestations and Management

Viruses, 2022
The Varicella-zoster virus (VZV) or human herpes virus 3 is a neurotropic human alpha herpes virus responsible for chickenpox/varicella and shingles/Herpes zoster (HZ). This review will focus on HZ.
Anant D Patil, M. Goldust, U. Wollina
semanticscholar   +1 more source

Long-term Protection Against Herpes Zoster by the Adjuvanted Recombinant Zoster Vaccine: Interim Efficacy, Immunogenicity, and Safety Results up to 10 Years After Initial Vaccination

Open Forum Infectious Diseases, 2022
Approximately 10 years after vaccination with the recombinant zoster vaccine (RZV), an interim analysis of this follow-up study of the ZOE-50/70 trials demonstrated that efficacy against herpes zoster remained high.
A. Strezova, J. Díez-Domingo, Kamal Al Shawafi, J. Tinoco, Meng Shi, P. Pirrotta, A. Mwakingwe-Omari, Michael Anitta Charles Eugene Jose-Fernando Piero Elisabet Adams Ahonen Andrews Athan BarbaGómez Barbanti Bar, M. Adams, Anitta Ahonen, C. Andrews, E. Athan, Jose-Fernando BarbaGómez, P. Barbanti, Elisabeth Barberan, A. Baty, N. Bengtsson, J. Berger-Roscher, Katarina Berndtsson Blom, J. Beytout, Loïc Boucher, C. Boutry, Alain Boye, François Brault, Laurie Breger, Carles Brotons Cuixart, Covadonga Caso, Christine Cerna, Huey‐Shinn Cheng, H. Cheong, E. Choo, C. Cunha, A. Cunningham, D. Curiac, Benoit Daguzan, Antje Dahmen, S. Datta, M. Desole, Emmanuel Di Paolo, M. Dionne, P. Dítě, J. Dutz, J. Earl, Tamara Eckermann, W. Ellison, J. Eremenko, Meral Esen, Takashi Eto, Xavier Farrés Fabré, C. Farrington, Murdo Ferguson, P. Ferrand, M. Finneran, David Francyk, Marsha Freedman, George Freeman, Antônio Tarcísio Freire, P. Gal, Jean-Sébastien Gauthier, B. Gerlach, W. Ghesquiere, I. Gorfinkel, Christine Grigat, J. Grosskopf, Monika Hamann, Pascal Hanrion, P. Hartley, Andrew Hastie, Ken Heaton, Agnes Himpel-Boenninghoff, T. Horácek, D. S. Hui, Yieng Huong, Shinn-Jang Hwang, G. Icardi, Gabriele Illies, J. Irimajiri, W. Jacob, A. Jambrecina, T. Avelino-Silva, G. Kalema, Hyo Youl Kim, C. Klein, U. Kleinecke, H. Koenig, Satu Kokko, P. Kosina, Susan V. Koski, Pekka Koskinen, Maximilian Kropp, Rie Kuroki, Outi Laajalahti, P. Lachance, Jacob Lee, Jin-Soo Lee, P. Levins, R. Lipetz, Bo Liu, Chiu-Shong Liu, Martin Lundvall, Luci Magimaiseelan, Mary Beth Manning, Jukka Markkula, Frederick H. Martin, Pyrene Martínez Piera, D. McNally, S. Mcneil, G. Migliorino, B. Moeckesch, Stephan Morscher, Michael Mueller, Abul Kashem Mohammad Munir, C. M. de Oliveira, Kenjiro Nakamura, Sílvia Narejos Pérez, Yuji Naritomi, P. Nault, José Luiz Neto, C. López, Hiroaki Ogata, Å. Olsson, P. Paavola, D. Park, Jan Patrick, K. Pauksens, Mercè Pérez Vera, L. Peltonen, Georg Plassmann, A. Põder, Terry L. Poling, Carol Pretswell, Samir Purnell-Mullick, George Raad, M. Redmond, Philippe Remaud, E. Riffer, Patrick Robert, Alex Rodríguez Badia, María Luisa Rodríguez de la Pinta, L. Rombo, R. Rosen, Shari Rozen, Dominique Saillard, B. Salaun, J. S. Berglund, J. Sauter, A. Schaefer, Isabelle Schenkenberger, Juergen Schmidt, Bernhard Schmitt, C. Schubert, A. Schuind, T. Schwarz, Ilkka Seppa, Edmund Kwok Yiu Sha, G. Shockey, Sylvia Shoffner, Elina Sirnela-Rif, T. Staniscia, H. Sueki, Shin-ichi Suzuki, D. Taminau, G. Tellier, Manuel Terns Riera, Azhar Toma, Nicole Toursarkissian, M. Turner, Benita Ukkonen, Anna Vilella Morató, Juergen Wachter, Brian Webster, Karl Wilhelm, Jonathan Wilson, Wilfred W Yeo, Chong-Jen Yu, T. Zahaf, I. Zahharova, C. Zerbini   +177 more
semanticscholar   +1 more source